Cafepharma Today

January 14 2025 - 5 questions facing emerging biotech in 2025
5 questions facing emerging biotech in 2025
Healthcare dealmakers eye M&A resurgence in second Trump term
Reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance
Merck is broadening its pipeline as Keytruda’s patent cliff looms
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Mylan receives tentative FDA nod for generic version of antidepressant Effexor XR
RTT News
Monday, November 17, 2008 - 8:31am
tags:
Gains By Democrats Put Pharma On Edge
Yahoo/Investors Business Daily
Monday, November 17, 2008 - 8:23am
tags:
Lilly takes stake in United Therapeutics, enters pacts
Marketwatch
Monday, November 17, 2008 - 8:19am
tags:
Eat Your Statins
Forbes
Monday, November 17, 2008 - 8:18am
tags:
Merck Rolls the Dice on New Januvia Study
Seeking Alpha
Monday, November 17, 2008 - 8:17am
tags:
Molecular Insight loss widens
Bizjournals.com
Saturday, November 15, 2008 - 10:24am
tags:
Jazz Pharma cuts 67 jobs, Q3 loss grows to $28.8M
Bizjournals.com
Saturday, November 15, 2008 - 10:19am
tags:
BioSeek licenses 2 anti-inflammatory peptides from Amylin
Bizjournals.com
Saturday, November 15, 2008 - 10:18am
tags:
Isotechnika reports third quarter financial results
CNW Telbec
Saturday, November 15, 2008 - 10:11am
tags:
Inotek Pharmaceuticals granted two new US patents
Pharmaceutical Business Review
Saturday, November 15, 2008 - 9:58am
tags:
Lexicon Pharmaceuticals completes Phase I carcinoid syndrome trial
Pharmaceutical Business Review
Saturday, November 15, 2008 - 9:56am
tags:
Pfizer Focus on Stem Cells Could Help Some Biotechs
TMC Net
Saturday, November 15, 2008 - 9:53am
tags:
Dragon Pharma Reports 2008 Third Quarter Financial Results
CNN Money
Saturday, November 15, 2008 - 9:50am
tags:
Gilead says Teva files to sell generic of HIV drug
Alertnet
Saturday, November 15, 2008 - 9:46am
tags:
Merck Rolls The Dice On Januvia
CNBC
Saturday, November 15, 2008 - 9:44am
tags:
Gilead Sciences Announces Notification of ANDA Filing for Truvada
Yahoo
Saturday, November 15, 2008 - 9:42am
tags:
FDA Reports Side Effects Linked to Wrinkle Fillers
Wall Street Journal
Saturday, November 15, 2008 - 9:42am
tags:
OXiGENE Receives NASDAQ Notification
Yahoo
Saturday, November 15, 2008 - 9:40am
tags:
BioSante: Key Support Is Back
Seeking Alpha
Saturday, November 15, 2008 - 9:39am
tags:
Bristol-Myers And The 2 Percent Solution
Pharmalot
Friday, November 14, 2008 - 10:18am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Why 340B Reform Could Happen in 2025 (video)
Drug Channels
Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late!
Drug Channels
The Pain Comes With the Territory
In the Pipeline
A New Antiviral Target, On the Host Side
In the Pipeline
Inside a Fentanyl Kitchen
In the Pipeline
Inflation-Adjusted U.S. Brand-Name Drug Prices Fell for the Seventh Consecutive Year as a New Era of Drug Pricing Dawns
Drug Channels
Carbyne Remains Elusive
In the Pipeline
Another GLP-1 Year
In the Pipeline
Two More Great Names Pass
In the Pipeline

Latest Jobs

Account Executive
McAlester, Oklahoma, 74502
Elara Caring
Account Executive
San Antonio, Texas, 78284
Elara Caring
Account Executive
Wichita Falls, Texas, 76309
Elara Caring
Account Executive
Dallas, Texas, 75219
Elara Caring
Account Executive, Home Health
Austin, Texas, 78703
AccentCare, Inc.
Account Executive
Monroe, Louisiana, 71201
Elara Caring
Account Executive
Clinton Township, Michigan, 48036
Elara Caring
Sales Representative- Wilmington/Harrisburg- Communications
Lancaster, Pennsylvania, 17699
Stryker
Sales Representative- Southern MD- Communications
Washington, District of Columbia, 20080
Stryker
Account Executive, Home Health
Temple, Texas, 76504
AccentCare, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information